Circulating MCP-1 levels in COVID-19 patients increased with age revealing the highest MCP-1 levels in older individuals with an unfavorable outcome, indicating that not only age, but also unfavorable outcome is cause or consequence of increased MCP-1. This evidence concerns the gene CCL2 and COVID-19.